Noticias y Actualidad del Cannabis

ESPAÑA:

El 84% de los españoles, quieren regular el uso médico de la Marihuana

La empresa valenciana Hemps Pharma lanza la primera crema analgésica con cannabis para deportistas

 

EUROPA:

Luxembourg’s new government releases details on recreational cannabis proposal.

The EMCDDA publishes a guide to medical cannabis policymaking.

Israeli government passes first vote on medical cannabis export bill.

German cultivation tender faces further delays.

UK patients begin receiving medical cannabis licences, but treatment remains costly.

Canopy Growth acquires German vape manufacturers Storz & Bickel.

Aurora ships medical cannabis to Luxembourg.

A Turkish rapper is challenging the country’s strict cannabis laws.

CBD oil continues to seep into the UK beauty industry.

 

AMÉRICA:

Marlboro apuesta fuertemente por el cannabis

Novedades desde Puerto Rico

Inside Colombia’s Canadian cannabis investment boom.

Tilray completes acquisition of Alef Biotechnology and rebrands as Tilray Latin America.

Former Mexican President Vicente Fox says Trump should ‘go for’ cannabis legalisation.

Canada’s draft rules for cannabis edibles expected in coming weeks.

A proposed farming bill could clear a legal path for hemp-derived CBD in the US.

New Yorkers want to legalise cannabis to pay for new transport infrastructure.

Cronos sells 45% stake to Altria Group for $1.8 billion.

 

OCEANÍA:

Wayland Group strikes medical cannabis cultivation deal in the Northern Territory.

Changes to New Zealand’s medical cannabis bill offers amnesty for local growers.

Australia’s MedLab launches European subsidiary.

Little Green Pharma plans to list on the Frankfurt Stock Exchange.

Enterprise software company 365 Cannabis expands into Australia.

 

RESTO DEL MUNDO:

Philippines President Rodrigo Duterte favours the regulation of medical cannabis.

South Korea’s move to legalise medical cannabis is causing cultural confusion.

 

SALUD Y CIENCIA:

Cannabis researchers say they have found a way to increase rare THCV production.

Canopy invests $9.5 million into UK cannabis trials for pain and opioid dependence.

Cannabis holds the potential to treat diabetes but further study is required.

Research is needed on the environmental impact of cannabis legalisation.

 

  • Fuentes: propias y de Prohibition Partners (muchas gracias)